Several lipid lowering strategies targeting PCSK9 have been designed to manage hypercholesterolemia.
PCSK9 mediates several physiological effects, which are independent of cholesterol homeostasis.
Long-term PCSK9 inhibition may detrimentally affect these physiological effects and therefore should be carefully evaluated.